Literature DB >> 22747918

Extracorporeal membrane oxygenation for critically ill patients with 2009 influenza A (H1N1)-related acute respiratory distress syndrome: preliminary experience from a single center.

Xiaotong Hou1, Limin Guo, Qingyuan Zhan, Xiaojun Jia, Yuhong Mi, Baoshun Li, Bin Sun, Xing Hao, Hui Li.   

Abstract

From early May 2009, the novel influenza A (H1N1) pandemic affected mainland China. Of those infected, a small proportion of patients developed acute respiratory distress syndrome (ARDS) so rapidly and severely that conventional ventilation treatment was ineffective. As an alternative treatment, the effect of extracorporeal membrane oxygenation (ECMO) was evaluated. From November 2009 to January 2010, all patients suffering from influenza A (H1N1)-associated ARDS referred to Beijing Anzhen Hospital for treatment with ECMO were enrolled. We describe the characteristics, treatment, and outcomes of these patients at 1- and 3-month follow-up. Nine patients (four females; mean age, 31.2 [21-59] years) from four centers were enrolled. All females had a history of recent pregnancy or had recently given birth. Before ECMO, patients had severe respiratory failure despite advanced mechanical ventilatory support with a mean partial pressure of arterial oxygen/fraction of inspired oxygen of 52.9 ± 5.1 (45.0-63.8) mm Hg, positive end-expiratory pressure of 17.2 ± 4.2 cmH(2) O, and a Murray Lung Score of 3.6 (3.25-3.75). All nine patients were treated with veno-venous ECMO via percutaneous access. The mean duration of ECMO support was 436.6 ± 652.1 h (67.0-2160.0). At the end of 1-year follow-up, five patients (55.7%) were weaned from ECMO. Five patients (55.7%) survived to hospital discharge. Four patients (44.4%) died while undergoing ECMO. The mean length of intensive care unit and hospital stay was 4-204 days (median, 32) and 4-234 days (median, 38), respectively. There was no significant difference between survivors and nonsurvivors in the screened parameters. Use of ECMO for critically ill patients with 2009 influenza A (H1N1)-related ARDS is feasible and effective. However, this treatment is technically demanding. For success, careful selection of patients is crucial.
© 2012, Copyright the Authors. Artificial Organs © 2012, International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22747918     DOI: 10.1111/j.1525-1594.2012.01468.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  8 in total

Review 1.  Extracorporeal gas exchange for acute respiratory failure in adult patients: a systematic review.

Authors:  Matthieu Schmidt; Carol Hodgson; Alain Combes
Journal:  Crit Care       Date:  2015-03-16       Impact factor: 9.097

2.  A study protocol for an observational cohort investigating COGnitive outcomes and WELLness in survivors of critical illness: the COGWELL study.

Authors:  M Elizabeth Wilcox; Andrew S Lim; Mary P McAndrews; Richard A Wennberg; Ruxandra L Pinto; Sandra E Black; Karolina D Walczak; Jan O Friedrich; Michael S Taglione; Gordon D Rubenfeld
Journal:  BMJ Open       Date:  2017-07-13       Impact factor: 2.692

3.  Extracorporeal Life Support in Pregnancy: A Systematic Review.

Authors:  Emily E Naoum; Andrew Chalupka; Jonathan Haft; Mark MacEachern; Cosmas J M Vandeven; Sarah Rae Easter; Michael Maile; Brian T Bateman; Melissa E Bauer
Journal:  J Am Heart Assoc       Date:  2020-06-24       Impact factor: 5.501

4.  Extracorporeal Membrane Oxygenation Support for Influenza A: Retrospective Review of the Extracorporeal Life Support Organization Registry Comparing H1N1 With Other Subtypes.

Authors:  Erika R O'Neil; Huiming Lin; Meng Li; Lara Shekerdemian; Joseph E Tonna; Ryan P Barbaro; Jayvee R Abella; Peter Rycus; Graeme MacLaren; Marc M Anders; Peta M A Alexander
Journal:  Crit Care Explor       Date:  2021-12-09

5.  Severe influenza treatment guideline.

Authors:  Won Suk Choi; Ji Hyeon Baek; Yu Bin Seo; Sae Yoon Kee; Hye Won Jeong; Hee Young Lee; Byung Wook Eun; Eun Ju Choo; Jacob Lee; Young Keun Kim; Joon Young Song; Seong-Heon Wie; Jin Soo Lee; Hee Jin Cheong; Woo Joo Kim
Journal:  Korean J Intern Med       Date:  2014-01-02       Impact factor: 2.884

Review 6.  Extracorporeal Membrane Oxygenation as a Bridge for Heart Failure and Cardiogenic Shock.

Authors:  Zhao-Peng Zhong; Hong Wang; Xiao-Tong Hou
Journal:  Biomed Res Int       Date:  2016-05-16       Impact factor: 3.411

7.  Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus.

Authors:  Mohammed S Alshahrani; Anees Sindi; Fayez Alshamsi; Awad Al-Omari; Mohamed El Tahan; Bayan Alahmadi; Ahmed Zein; Naif Khatani; Fahad Al-Hameed; Sultan Alamri; Mohammed Abdelzaher; Amenah Alghamdi; Faisal Alfousan; Adel Tash; Wail Tashkandi; Rajaa Alraddadi; Kim Lewis; Mohammed Badawee; Yaseen M Arabi; Eddy Fan; Waleed Alhazzani
Journal:  Ann Intensive Care       Date:  2018-01-10       Impact factor: 6.925

8.  Extracorporeal membrane oxygenation in pregnant and postpartum women: a ten-year case series.

Authors:  Carolyn M Webster; Kathleen A Smith; Tracy A Manuck
Journal:  Am J Obstet Gynecol MFM       Date:  2020-03-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.